TY - JOUR AU - Mendelsohn, J. PY - 2013 DA - 2013// TI - Personalizing oncology: perspectives and prospects JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.45.3605 DO - 10.1200/JCO.2012.45.3605 ID - Mendelsohn2013 ER - TY - JOUR AU - Douillard, J. -. Y. AU - Oliner, K. S. AU - Siena, S. AU - Tabernero, J. AU - Burkes, R. AU - Barugel, M. PY - 2013 DA - 2013// TI - Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1305275 DO - 10.1056/NEJMoa1305275 ID - Douillard2013 ER - TY - JOUR AU - Mok, T. S. AU - Wu, Y. L. AU - Thongprasert, S. AU - Yang, C. H. AU - Chu, D. T. AU - Saijo, N. PY - 2009 DA - 2009// TI - Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma JO - N Engl J Med VL - 361 UR - https://doi.org/10.1056/NEJMoa0810699 DO - 10.1056/NEJMoa0810699 ID - Mok2009 ER - TY - JOUR AU - Normanno, N. AU - Rachiglio, A. M. AU - Roma, C. AU - Fenizia, F. AU - Esposito, C. AU - Pasquale, R. PY - 2013 DA - 2013// TI - Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities JO - J Cell Biochem VL - 114 UR - https://doi.org/10.1002/jcb.24401 DO - 10.1002/jcb.24401 ID - Normanno2013 ER - TY - JOUR AU - Garraway, L. A. PY - 2013 DA - 2013// TI - Genomics-Driven Oncology: Framework for an Emerging Paradigm JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.46.8934 DO - 10.1200/JCO.2012.46.8934 ID - Garraway2013 ER - TY - JOUR AU - Li, T. H. AU - Kung, H. J. AU - Mack, P. C. AU - Gandara, D. R. PY - 2013 DA - 2013// TI - Genotyping and Genomic Profiling of Non-Small-Cell Lung Cancer: Implications for Current and Future Therapies JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.45.3753 DO - 10.1200/JCO.2012.45.3753 ID - Li2013 ER - TY - JOUR AU - Coghlin, C. L. AU - Smith, L. J. AU - Bakar, S. AU - Stewart, K. N. AU - Devereux, G. S. AU - Nicolson, M. C. PY - 2010 DA - 2010// TI - Quantitative analysis of tumour in bronchial biopsy specimens JO - J Thorac Oncol VL - 5 UR - https://doi.org/10.1097/JTO.0b013e3181ca12c4 DO - 10.1097/JTO.0b013e3181ca12c4 ID - Coghlin2010 ER - TY - JOUR AU - Dienstmann, R. AU - Rodon, J. AU - Barretina, J. AU - Tabernero, J. PY - 2013 DA - 2013// TI - Genomic medicine frontier in human solid tumors: prospects and challenges JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.45.2268 DO - 10.1200/JCO.2012.45.2268 ID - Dienstmann2013 ER - TY - JOUR AU - Tian, S. AU - Simon, I. AU - Moreno, V. AU - Roepman, P. AU - Tabernero, J. AU - Snel, M. PY - 2013 DA - 2013// TI - A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction JO - Gut VL - 62 UR - https://doi.org/10.1136/gutjnl-2012-302423 DO - 10.1136/gutjnl-2012-302423 ID - Tian2013 ER - TY - JOUR AU - Yokota, T. AU - Ura, T. AU - Shibata, N. AU - Takahari, D. AU - Shitara, K. AU - Nomura, M. PY - 2011 DA - 2011// TI - BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer JO - Br J Cancer VL - 104 UR - https://doi.org/10.1038/bjc.2011.19 DO - 10.1038/bjc.2011.19 ID - Yokota2011 ER - TY - JOUR AU - Carpten, J. D. AU - Faber, A. L. AU - Horn, C. AU - Donoho, G. P. AU - Briggs, S. L. AU - Robbins, C. M. PY - 2007 DA - 2007// TI - A transforming mutation in the pleckstrin homology domain of AKT1 in cancer JO - Nature VL - 448 UR - https://doi.org/10.1038/nature05933 DO - 10.1038/nature05933 ID - Carpten2007 ER - TY - JOUR AU - Day, E. AU - Waters, B. AU - Spiegel, K. AU - Alnadaf, T. AU - Manley, P. W. AU - Buchdunger, E. PY - 2008 DA - 2008// TI - Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib JO - Eur J Pharmacol VL - 599 UR - https://doi.org/10.1016/j.ejphar.2008.10.014 DO - 10.1016/j.ejphar.2008.10.014 ID - Day2008 ER - TY - JOUR AU - Hammerman, P. S. AU - Sos, M. L. AU - Ramos, A. H. AU - Xu, C. AU - Dutt, A. AU - Zhou, W. PY - 2011 DA - 2011// TI - Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer JO - Canc Discov VL - 1 UR - https://doi.org/10.1158/2159-8274.CD-11-0005 DO - 10.1158/2159-8274.CD-11-0005 ID - Hammerman2011 ER - TY - JOUR AU - Arcila, M. E. AU - Chaft, J. E. AU - Nafa, K. AU - Roy-Chowdhuri, S. AU - Lau, C. AU - Zaidinski, M. PY - 2012 DA - 2012// TI - Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas JO - Clin Canc Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-0912 DO - 10.1158/1078-0432.CCR-12-0912 ID - Arcila2012 ER - TY - JOUR AU - Greve, J. AU - Teugels, E. AU - Geers, C. AU - Decoster, L. AU - Galdermans, D. AU - Mey, J. PY - 2012 DA - 2012// TI - Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu JO - Lung Cancer VL - 76 UR - https://doi.org/10.1016/j.lungcan.2012.01.008 DO - 10.1016/j.lungcan.2012.01.008 ID - Greve2012 ER - TY - JOUR AU - Mazieres, J. AU - Peters, S. AU - Lepage, B. AU - Cortot, A. B. AU - Barlesi, F. AU - Beau-Faller, M. PY - 2013 DA - 2013// TI - Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.45.6095 DO - 10.1200/JCO.2012.45.6095 ID - Mazieres2013 ER - TY - JOUR AU - Williams, C. AU - Ponten, F. AU - Moberg, C. AU - Soderkvist, P. AU - Uhlen, M. AU - Ponten, J. PY - 1999 DA - 1999// TI - A high frequency of sequence alterations is due to formalin fixation of archival specimens JO - Am J Pathol VL - 155 UR - https://doi.org/10.1016/S0002-9440(10)65461-2 DO - 10.1016/S0002-9440(10)65461-2 ID - Williams1999 ER - TY - JOUR AU - Endris, V. AU - Penzel, R. AU - Warth, A. AU - Muckenhuber, A. AU - Schirmacher, P. AU - Stenzinger, A. PY - 2013 DA - 2013// TI - Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing JO - The Journal of molecular diagnostics VL - 15 UR - https://doi.org/10.1016/j.jmoldx.2013.06.002 DO - 10.1016/j.jmoldx.2013.06.002 ID - Endris2013 ER - TY - JOUR AU - Beadling, C. AU - Neff, T. L. AU - Heinrich, M. C. AU - Rhodes, K. AU - Thornton, M. AU - Leamon, J. PY - 2013 DA - 2013// TI - Combining highly multiplexed PCR with semiconductor-based sequencing for rapid cancer genotyping JO - The Journal of molecular diagnostics: JMD VL - 15 UR - https://doi.org/10.1016/j.jmoldx.2012.09.003 DO - 10.1016/j.jmoldx.2012.09.003 ID - Beadling2013 ER - TY - JOUR AU - Hadd, A. G. AU - Houghton, J. AU - Choudhary, A. AU - Sah, S. AU - Chen, L. AU - Marko, A. C. PY - 2013 DA - 2013// TI - Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens JO - The Journal of molecular diagnostics: JMD VL - 15 UR - https://doi.org/10.1016/j.jmoldx.2012.11.006 DO - 10.1016/j.jmoldx.2012.11.006 ID - Hadd2013 ER - TY - JOUR AU - Zhou, Q. AU - Zhang, X. C. AU - Chen, Z. H. AU - Yin, X. L. AU - Yang, J. J. AU - Xu, C. R. PY - 2011 DA - 2011// TI - Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancer JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.33.3757 DO - 10.1200/JCO.2010.33.3757 ID - Zhou2011 ER - TY - JOUR AU - Morabito, A. AU - Costanzo, R. AU - Rachiglio, A. M. AU - Pasquale, R. AU - Sandomenico, C. AU - Franco, R. PY - 2013 DA - 2013// TI - Activity of Gefitinib in a Non-Small-Cell Lung Cancer Patient with Both Activating and Resistance EGFR Mutations JO - J Thorac Oncol VL - 8 UR - https://doi.org/10.1097/JTO.0b013e318286cc26 DO - 10.1097/JTO.0b013e318286cc26 ID - Morabito2013 ER -